{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:16:19Z","timestamp":1786994179141,"version":"build-2736575974"},"reference-count":249,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2025\/03\/37873"],"award-info":[{"award-number":["PSAU\/2025\/03\/37873"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.micpath.2026.108592","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:08:50Z","timestamp":1779721730000},"page":"108592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Connecting the dots between phage pharmacokinetics, pharmacodynamics and immune interactions"],"prefix":"10.1016","volume":"217","author":[{"given":"El-Sayed","family":"Khafagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza A.H.","family":"Rajab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al Saqr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-4803","authenticated-orcid":false,"given":"Wael A.H.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108592_bib1","article-title":"Bacteriophage resurrection: innovative impacts in medicine, biotechnology, and environmental solutions","volume":"27","author":"Rizvi","year":"2025","journal-title":"Sci. Afr."},{"key":"10.1016\/j.micpath.2026.108592_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches","volume":"83","author":"Chanishvili","year":"2012","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.micpath.2026.108592_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: a growing serious threat for global public health","volume":"11","author":"Salam","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.micpath.2026.108592_bib4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00203-020-02167-5","article-title":"Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts","volume":"203","author":"Royer","year":"2021","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.micpath.2026.108592_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: a renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell host & microbe"},{"key":"10.1016\/j.micpath.2026.108592_bib7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cmi.2022.01.006","article-title":"The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice","volume":"28","author":"Chang","year":"2022","journal-title":"Clin. Microbiol. Infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.micpath.2026.108592_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.01384-25","article-title":"Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa","volume":"10","author":"Cha","year":"2025","journal-title":"mSystems"},{"key":"10.1016\/j.micpath.2026.108592_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cmi.2023.01.021","article-title":"Pharmacokinetics\/pharmacodynamics of phage therapy: a major hurdle to clinical translation","volume":"29","author":"Nang","year":"2023","journal-title":"Clin. Microbiol. Infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.micpath.2026.108592_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v11060557","article-title":"Hurdles for phage therapy to become a Reality-An editorial comment","volume":"11","author":"Brussow","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib11","article-title":"Limitations of phage therapy and corresponding optimization strategies: a review","volume":"27","author":"Lin","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2026.108592_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ph19010162","article-title":"Phage therapy at the crossroads between clinical promise and regulatory challenge","volume":"19","author":"Gallina","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2026.108592_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage therapy: clinical trials and regulatory hurdles","volume":"8","author":"Furfaro","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fmicb.2014.00051","article-title":"The factors affecting effectiveness of treatment in phages therapy","volume":"5","author":"Ly-Chatain","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/v11010010","article-title":"Interactions between bacteriophage, bacteria, and the Mammalian immune System","volume":"11","author":"Van Belleghem","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.181309","article-title":"The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo","volume":"9","author":"Echterhof","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.micpath.2026.108592_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune System and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell host & microbe"},{"key":"10.1016\/j.micpath.2026.108592_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1250339","article-title":"Bacterial outer membrane vesicles bound to bacteriophages modulate neutrophil responses to bacterial infection","volume":"13","author":"Pennetzdorfer","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/idr16060092","article-title":"Advancing phage therapy: a comprehensive review of the safety, efficacy, and future prospects for the targeted treatment of bacterial infections","volume":"16","author":"Palma","year":"2024","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.micpath.2026.108592_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.956833","article-title":"Highly different effects of phage therapy and antibiotic therapy on immunological responses of chickens infected with Salmonella enterica serovar Typhimurium","volume":"13","author":"Grabowski","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/ijms27010172","article-title":"Analysis of Pro- and anti-inflammatory gene response patterns in patients receiving phage therapy","volume":"27","author":"Kasprzak","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108592_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2042098612469335","article-title":"The ABCD of clinical pharmacokinetics","volume":"4","author":"Doogue","year":"2013","journal-title":"Therapeutic advances in drug safety"},{"key":"10.1016\/j.micpath.2026.108592_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1067\/mcp.2000.109520","article-title":"Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals","volume":"68","author":"Payne","year":"2000","journal-title":"Clinical pharmacology and therapeutics"},{"key":"10.1016\/j.micpath.2026.108592_bib24","article-title":"A phage therapy guide for Clinicians and basic scientists: background and highlighting applications for developing countries","volume":"11","author":"Khalid","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.2042-7158.2011.01324.x","article-title":"Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy","volume":"63","author":"Ryan","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108592_bib26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s12275-024-00185-2","article-title":"Characterization and comparative genomic analysis of vB_BceM_CEP1: a novel temperate bacteriophage infecting Burkholderia cepacia complex","volume":"62","author":"Askoura","year":"2024","journal-title":"J. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01874-17","article-title":"Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers","volume":"8","author":"Nguyen","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108592_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41385-019-0250-5","article-title":"New insights into intestinal phages","volume":"13","author":"Sausset","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib29","first-page":"4","article-title":"Phage therapy administration route, regimen, and need for supplementary antibiotics in patients with chronic suppurative lung disease","volume":"4","author":"Williams","year":"2023","journal-title":"Phage"},{"key":"10.1016\/j.micpath.2026.108592_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199442","article-title":"Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage","volume":"348","author":"Singh","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2026.108592_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00408-024-00700-7","article-title":"Phage therapy for respiratory infections: opportunities and challenges","volume":"202","author":"Khosravi","year":"2024","journal-title":"Lung"},{"key":"10.1016\/j.micpath.2026.108592_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12967-019-2120-z","article-title":"Exploring the whole standard operating procedure for phage therapy in clinical practice","volume":"17","author":"Cui","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.micpath.2026.108592_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094577","article-title":"Phage therapy in the era of multidrug resistance in bacteria: a systematic review","volume":"23","author":"Aranaga","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108592_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107570","article-title":"Clinical application of customized and non-customized bacteriophage therapy in patients with refractory\/resistant bacterial infections: a systematic review and meta-analysis","volume":"66","author":"Liu","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108592_bib35","doi-asserted-by":"crossref","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single Center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108592_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciac453","article-title":"Phage therapy of mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease","volume":"76","author":"Dedrick","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108592_bib37","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","article-title":"Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection","volume":"27","author":"Dedrick","year":"2021","journal-title":"Nature medicine"},{"key":"10.1016\/j.micpath.2026.108592_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/jiac368","article-title":"Development of host immune response to bacteriophage in a lung transplant recipient on adjunctive phage therapy for a multidrug-resistant pneumonia","volume":"227","author":"Dan","year":"2023","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.micpath.2026.108592_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/v13071268","article-title":"The safety and toxicity of phage therapy: a review of animal and clinical studies","volume":"13","author":"Liu","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib40","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"The Lancet Infectious diseases"},{"key":"10.1016\/j.micpath.2026.108592_bib41","article-title":"The safety of bacteriophages in treatment of diseases caused by multidrug-resistant bacteria","volume":"16","author":"Chung","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2026.108592_bib42","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/med.21572","article-title":"Phage therapy: what factors shape phage pharmacokinetics and bioavailability? Systematic and critical review","volume":"39","author":"D\u0105browska","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.micpath.2026.108592_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaf121","article-title":"In vivo pharmacokinetics, therapeutic efficacy and immune response of bacteriophage vB_AbaSt_W16 against carbapenem-resistant Acinetobacter baumannii","volume":"7","author":"Choi","year":"2025","journal-title":"JAC-antimicrobial resistance"},{"key":"10.1016\/j.micpath.2026.108592_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.107058","article-title":"In vitro and in vivo assessment of the competence of a novel lytic phage vB_EcoS_UTEC10 targeting multidrug resistant Escherichia coli with a robust biofilm eradication activity","volume":"197","author":"Rajab","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108592_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxaf028","article-title":"Combating enteropathogenic and multidrug resistant Escherichia coli using the lytic bacteriophage vB_EcoM_ECO78, which disrupts bacterial biofilm formation and exhibits a remarkable environmental stability","volume":"136","author":"Rajab","year":"2025","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.684704","article-title":"Pharmacokinetics and pharmacodynamics of a novel virulent Klebsiella phage Kp_Pokalde_002 in a mouse model","volume":"11","author":"Dhungana","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.613356","article-title":"Safety and efficacy of a phage, kpssk3, in an in vivo model of carbapenem-resistant hypermucoviscous Klebsiella pneumoniae bacteremia","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107220","article-title":"Phage therapy combats pandrug-resistant Acinetobacter baumannii infection safely and efficiently","author":"Wang","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108592_bib49","article-title":"Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection","volume":"69","author":"Zagaliotis","year":"2024","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"10.1016\/j.micpath.2026.108592_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/649227","article-title":"Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection","volume":"201","author":"Carmody","year":"2010","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.micpath.2026.108592_bib51","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/AAC.01028-06","article-title":"Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model","volume":"51","author":"McVay","year":"2007","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.micpath.2026.108592_bib52","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/649227","article-title":"Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection","volume":"201","author":"Carmody","year":"2010","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.micpath.2026.108592_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00607-24","article-title":"Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae","volume":"9","author":"Zhao","year":"2024","journal-title":"mSystems"},{"key":"10.1016\/j.micpath.2026.108592_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaf121","article-title":"In vivo pharmacokinetics, therapeutic efficacy and immune response of bacteriophage vB_AbaSt_W16 against carbapenem-resistant Acinetobacter baumannii","volume":"7","author":"Choi","year":"2025","journal-title":"JAC-antimicrobial resistance"},{"key":"10.1016\/j.micpath.2026.108592_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.684704","article-title":"Pharmacokinetics and pharmacodynamics of a novel virulent Klebsiella phage Kp_Pokalde_002 in a mouse model","volume":"11","author":"Dhungana","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib56","first-page":"359","article-title":"Comparative analysis of immune responses to intraperitoneal administration of lytic E. coli bacteriophages in mice","author":"Alexyuk","year":"2025","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2026.108592_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14787210.2017.1265447","article-title":"Delivering phage therapy per os: benefits and barriers","volume":"15","author":"Zelasko","year":"2017","journal-title":"Expert review of anti-infective therapy"},{"key":"10.1016\/j.micpath.2026.108592_bib58","doi-asserted-by":"crossref","DOI":"10.1186\/s13099-025-00735-y","article-title":"Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infections","volume":"17","author":"Youssef","year":"2025","journal-title":"Gut Pathog."},{"key":"10.1016\/j.micpath.2026.108592_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.micpath.2026.108592_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121206","article-title":"Enteric-coated bacteriophage tablets for oral administration against gastrointestinal infections","author":"Khanal","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2026.108592_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061602","article-title":"Eudragit\u00ae FS microparticles containing bacteriophages, prepared by spray-drying for oral administration","volume":"15","author":"Tabare","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108592_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/v17091205","article-title":"Development of an acid-protective polymer encapsulation formulation for oral delivery of salmonella phages","volume":"17","author":"Bernela","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib63","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/17425247.2017.1252329","article-title":"Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections","volume":"14","author":"Bodier-Montagutelli","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.micpath.2026.108592_bib64","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0121-2022","article-title":"Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations","volume":"31","author":"Mitropoulou","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.micpath.2026.108592_bib65","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.addr.2018.08.001","article-title":"Phage therapy for respiratory infections","volume":"133","author":"Chang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2026.108592_bib66","article-title":"Proof-of-Principle Study in a murine lung infection model of antipseudomonal activity of phage PEV20 in a dry-powder formulation","volume":"62","author":"Chang","year":"2017","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.micpath.2026.108592_bib67","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41551-018-0263-5","article-title":"Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections","volume":"2","author":"Agarwal","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.micpath.2026.108592_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01470-20","article-title":"Pharmacokinetics and time-kill Study of inhaled antipseudomonal bacteriophage therapy in mice","volume":"65","author":"Chow","year":"2020","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.micpath.2026.108592_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/v14010033","article-title":"Preclinical assessment of bacteriophage therapy against experimental Acinetobacter baumannii lung infection","volume":"14","author":"Wienhold","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10080946","article-title":"Successful intratracheal treatment of phage and antibiotic combination therapy of a multi-drug resistant Pseudomonas aeruginosa Murine Model","volume":"10","author":"Duplessis","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108592_bib71","article-title":"Expanding clinical phage microbiology: simulating phage inhalation for respiratory tract infections","volume":"7","author":"Porat","year":"2021","journal-title":"ERJ Open Research"},{"key":"10.1016\/j.micpath.2026.108592_bib72","article-title":"Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa","volume":"14","author":"K\u00f6hler","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108592_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.758392","article-title":"Prospects of inhaled phage therapy for combatting pulmonary infections","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.2214","article-title":"Reapproaching old treatments: considerations for PK\/PD studies on phage therapy for bacterial respiratory infections","volume":"109","author":"Schmalstig","year":"2021","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.micpath.2026.108592_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17081077","article-title":"Latest advances in inhalable dry powder bacteriophage therapy for pulmonary infections","volume":"17","author":"Encinas-Basurto","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108592_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040405","article-title":"Development of inhalable bacteriophage liposomes against Pseudomonas aeruginosa","volume":"17","author":"Sawant","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108592_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01696","article-title":"Applications of bacteriophages in the treatment of localized infections in humans","volume":"9","author":"Morozova","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9110754","article-title":"The safety and efficacy of phage therapy for superficial bacterial infections: a systematic review","volume":"9","author":"Steele","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108592_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/medicina60050790","article-title":"How effective is phage therapy for prosthetic joint infections? A preliminary systematic review and proportional meta-analysis of early outcomes","volume":"60","author":"Young","year":"2024","journal-title":"Medicina"},{"key":"10.1016\/j.micpath.2026.108592_bib80","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad533","article-title":"Phage therapy as a novel therapeutic for the treatment of bone and joint infections","volume":"77","author":"Suh","year":"2023","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.micpath.2026.108592_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214403","article-title":"Hydrazone-crosslinked poly(oligoethylene glycol methacrylate)-based hydrogels with physically entrapped phage effectively control Pseudomonas aeruginosa infections in a burn wound model","volume":"177","author":"Walji","year":"2025","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.micpath.2026.108592_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120508","article-title":"Development of thermosensitive hydrogel wound dressing containing Acinetobacter baumannii phage against wound infections","author":"Yan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2026.108592_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2021.01.024","article-title":"Controlled-release of free bacteriophage nanoparticles from 3D-plotted hydrogel fibrous structure as potential antibacterial wound dressing","author":"Shen","year":"2021","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.micpath.2026.108592_bib84","article-title":"Design of Phage-Cocktail\u2013Containing hydrogel for the treatment of Pseudomonas aeruginosa\u2013Infected wounds","volume":"15","author":"Kheljan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib85","article-title":"Pharmacokinetics and biodistribution of phages and their Current applications in antimicrobial therapy","volume":"7","author":"Kang","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.micpath.2026.108592_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02071-21","article-title":"Considerations for the use of phage therapy in clinical practice","volume":"66","author":"Suh","year":"2022","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.micpath.2026.108592_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.631794","article-title":"Animal models of phage therapy","volume":"12","author":"Penziner","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9110795","article-title":"The safety and efficacy of phage therapy for bone and joint infections: a systematic review","volume":"9","author":"Clarke","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108592_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1556\/1886.2024.00010","article-title":"Phage therapy in prosthetic joint infections caused by Staphylococcus aureus - a literature review","volume":"14","author":"Eiselt","year":"2024","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"10.1016\/j.micpath.2026.108592_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"Wright","year":"2009","journal-title":"Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery"},{"key":"10.1016\/j.micpath.2026.108592_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047742","article-title":"Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration","volume":"7","author":"Fukuda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108592_bib92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1874364101509010167","article-title":"Corneal infection therapy with topical bacteriophage administration","volume":"9","author":"Fadlallah","year":"2015","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.micpath.2026.108592_bib93","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12985-024-02510-y","article-title":"The potential use of bacteriophages as antibacterial agents in dental infection","volume":"21","author":"Hosseini","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2026.108592_bib94","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AEM.00096-15","article-title":"Targeting Enterococcus faecalis biofilms with phage therapy","volume":"81","author":"Khalifa","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib95","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0305-4179(94)90184-8","article-title":"Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa","volume":"20","author":"Soothill","year":"1994","journal-title":"Burns"},{"key":"10.1016\/j.micpath.2026.108592_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/v16071080","article-title":"Phage therapy in a burn patient colonized with extensively drug-resistant Pseudomonas aeruginosa responsible for relapsing ventilator-associated pneumonia and bacteriemia","volume":"16","author":"Teney","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib97","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/jbm.a.37728","article-title":"Bacteriophage-cocktail hydrogel dressing to prevent multiple bacterial infections and heal diabetic ulcers in mice","volume":"112","author":"Shiue","year":"2024","journal-title":"Journal of biomedical materials research Part A"},{"key":"10.1016\/j.micpath.2026.108592_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0312469","article-title":"Development of phage-containing hydrogel for treating Enterococcus faecalis-infected wounds","volume":"19","author":"Abed","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108592_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/v15030803","article-title":"Design of phage-cocktail-containing hydrogel for the treatment of Pseudomonas aeruginosa-Infected wounds","volume":"15","author":"Shafigh Kheljan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib100","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4239\/wjd.v14.i6.680","article-title":"What's old is new again: insights into diabetic foot microbiome","volume":"14","author":"Rajab","year":"2023","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.micpath.2026.108592_bib101","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with Pseudomonas aeruginosa","volume":"2018","author":"Chan","year":"2018","journal-title":"Evolution, medicine, and public health"},{"key":"10.1016\/j.micpath.2026.108592_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/cells12131720","article-title":"Phage interactions with the nervous System in health and disease","volume":"12","author":"Jedrusiak","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2026.108592_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136183","article-title":"Phage-Microbiota crosstalk: implications for central nervous System disorders","volume":"26","author":"Salari","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108592_bib104","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.7150\/thno.68636","article-title":"Phage display derived peptides for Alzheimer's disease therapy and diagnosis","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.micpath.2026.108592_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387044-5.00001-7","article-title":"Phage therapy pharmacology: calculating phage dosing","volume":"77","author":"Abedon","year":"2011","journal-title":"Adv. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib106","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2026.108592_bib107","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00702-23","article-title":"Liver sinusoidal cells eliminate blood-borne phage K1F","volume":"9","author":"S\u00e1nchez Romano","year":"2024","journal-title":"mSphere"},{"key":"10.1016\/j.micpath.2026.108592_bib108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2013.10.035","article-title":"Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice","volume":"449","author":"Bruckman","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2026.108592_bib109","first-page":"e01506","article-title":"Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model","volume":"70","author":"Echterhof","year":"2025","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.micpath.2026.108592_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00012-19","article-title":"Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies","volume":"83","author":"D\u0105browska","year":"2019","journal-title":"Microbiology and molecular biology reviews : MMBR (Microbiol. Mol. Biol. Rev.)"},{"key":"10.1016\/j.micpath.2026.108592_bib111","doi-asserted-by":"crossref","first-page":"81","DOI":"10.21775\/cimb.040.081","article-title":"Phage therapy: the pharmacology of antibacterial viruses","volume":"40","author":"Danis-Wlodarczyk","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.micpath.2026.108592_bib112","series-title":"Pharmacological and Immunological Action of Bacteriophages: Focus on Phage Therapy","author":"Gangwar","year":"2022"},{"key":"10.1016\/j.micpath.2026.108592_bib113","series-title":"Bacteriophage Pharmacology and Immunology. Bacteriophages: Biology, Technology, Therapy","first-page":"295","author":"D\u0105browska","year":"2021"},{"key":"10.1016\/j.micpath.2026.108592_bib114","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cmi.2023.01.021","article-title":"Pharmacokinetics\/pharmacodynamics of phage therapy: a major hurdle to clinical translation","volume":"29","author":"Nang","year":"2023","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.micpath.2026.108592_bib115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.12793\/tcp.2023.31.e17","article-title":"Phage-host-immune system dynamics in bacteriophage therapy: basic principles and mathematical models","volume":"31","author":"Chae","year":"2023","journal-title":"Translational and Clinical Pharmacology"},{"key":"10.1016\/j.micpath.2026.108592_bib116","article-title":"Bacteriophages presence in nature and their role in the natural selection of bacterial populations","volume":"91","author":"Naureen","year":"2020","journal-title":"Acta Biomed. : Atenei Parmensis"},{"key":"10.1016\/j.micpath.2026.108592_bib117","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1038\/s41467-024-51913-6","article-title":"Using bacterial population dynamics to count phages and their lysogens","volume":"15","author":"Geng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108592_bib118","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-micro-033121-020757","article-title":"Molecular basis of lysis\u2013lysogeny decisions in Gram-positive phages","volume":"75","author":"Brady","year":"2021","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib119","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41396-021-01096-5","article-title":"Genome-driven elucidation of phage-host interplay and impact of phage resistance evolution on bacterial fitness","volume":"16","author":"Markwitz","year":"2021","journal-title":"The ISME journal"},{"key":"10.1016\/j.micpath.2026.108592_bib120","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msac182","article-title":"Historical contingency drives compensatory evolution and rare reversal of phage resistance","volume":"39","author":"Debray","year":"2022","journal-title":"Mol. Biol. Evol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108592_bib121","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-virology-031413-085500","article-title":"Remarkable mechanisms in microbes to resist phage infections","volume":"1","author":"Dy","year":"2014","journal-title":"Annual review of virology."},{"key":"10.1016\/j.micpath.2026.108592_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128107","article-title":"Recent advancements in bacterial anti-phage strategies and the underlying mechanisms altering susceptibility to antibiotics","volume":"295","author":"Zou","year":"2025","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.micpath.2026.108592_bib123","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jtbi.2010.07.006","article-title":"Restriction-modification systems and bacteriophage invasion: who wins?","volume":"266","author":"Enikeeva","year":"2010","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.micpath.2026.108592_bib124","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/B978-0-12-394621-8.00011-X","article-title":"Role of CRISPR\/cas system in the development of bacteriophage resistance","volume":"82","author":"Szczepankowska","year":"2012","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.micpath.2026.108592_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/v10070351","article-title":"Resistance development to bacteriophages occurring during bacteriophage therapy","volume":"10","author":"Oechslin","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib126","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1093\/nar\/gkt1419","article-title":"A widespread bacteriophage abortive infection system functions through a Type IV toxin-antitoxin mechanism","volume":"42","author":"Dy","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2026.108592_bib127","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02169-23","article-title":"Bacteriophage P22 SieA-mediated superinfection exclusion","volume":"15","author":"Leavitt","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108592_bib128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15252\/embj.201489455","article-title":"BREX is a novel phage resistance system widespread in microbial genomes","volume":"34","author":"Goldfarb","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.micpath.2026.108592_bib129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41564-017-0051-0","article-title":"DISARM is a widespread bacterial defence system with broad anti-phage activities","volume":"3","author":"Ofir","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib130","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1038\/s41467-020-16703-w","article-title":"Structural and functional evidence of bacterial antiphage protection by Thoeris defense system via NAD(+) degradation","volume":"11","author":"Ka","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108592_bib131","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1093\/nar\/gkac467","article-title":"UG\/Abi: a highly diverse family of prokaryotic reverse transcriptases associated with defense functions","volume":"50","author":"Mestre","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2026.108592_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105732","article-title":"Phage resistance-mediated trade-offs with antibiotic resistance in Salmonella Typhimurium","volume":"171","author":"Laure","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108592_bib133","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00196-23","article-title":"Bacteriophage steering of Burkholderia cenocepacia toward reduced virulence and increased antibiotic sensitivity","volume":"205","author":"Ruest","year":"2023","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108592_bib134","doi-asserted-by":"crossref","DOI":"10.1093\/ismejo\/wraf065","article-title":"Phage-phage competition and biofilms affect interactions between two virulent bacteriophages and Pseudomonas aeruginosa","volume":"19","author":"Burkle","year":"2025","journal-title":"ISME J."},{"key":"10.1016\/j.micpath.2026.108592_bib135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12985-020-01485-w","article-title":"Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation","volume":"18","author":"Zurabov","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2026.108592_bib136","first-page":"279","article-title":"Phage therapy for severe bacterial infections: a narrative review","volume":"212","author":"Fabijan","year":"2019","journal-title":"MJA (Med. J. Aust.)"},{"key":"10.1016\/j.micpath.2026.108592_bib137","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cmi.2023.01.021","article-title":"Pharmacokinetics\/pharmacodynamics of phage therapy: a major hurdle to clinical translation","volume":"29","author":"Nang","year":"2023","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.micpath.2026.108592_bib138","doi-asserted-by":"crossref","DOI":"10.1080\/21597081.2016.1220348","article-title":"Phage therapy dosing: the problem(s) with multiplicity of infection (MOI)","volume":"6","author":"Abedon","year":"2016","journal-title":"Bacteriophage"},{"key":"10.1016\/j.micpath.2026.108592_bib139","first-page":"98","article-title":"Further considerations on how to improve phage therapy experimentation, practice, and reporting: pharmacodynamics perspectives","volume":"3","author":"Abedon","year":"2022","journal-title":"Therapy, Applications, and Research"},{"key":"10.1016\/j.micpath.2026.108592_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1292618","article-title":"A mechanism-based pathway toward administering highly active N-phage cocktails","volume":"14","author":"Smith","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib141","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/antibiotics12081329","article-title":"The potential of bacteriophage-antibiotic combination therapy in treating infections with multidrug-resistant bacteria","volume":"12","author":"Osman","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108592_bib142","article-title":"Phage-Antibiotic therapy as a promising strategy to combat multidrug-resistant infections and to enhance antimicrobial efficiency","volume":"11","author":"Liu","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108592_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011602","article-title":"Phage-antibiotic synergy: cell filamentation is a key driver of successful phage predation","volume":"19","author":"Bulssico","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108592_bib144","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/acsinfecdis.1c00117","article-title":"Synergistic effects of phage-antibiotic combinations against Citrobacter amalonaticus","volume":"8","author":"Manohar","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108592_bib145","article-title":"Phage-Antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Gu","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108592_bib146","article-title":"Phage-Antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Liu","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108592_bib147","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/jam.15647","article-title":"Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: in vitro synergy testing","volume":"133","author":"Holger","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115628","article-title":"Fitness trade-offs between phage and antibiotic sensitivity in phage-resistant variants: molecular action and insights into clinical applications for phage therapy","volume":"24","author":"Fujiki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108592_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108592_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071425","article-title":"Bacteriophage and bacterial susceptibility, resistance, and tolerance to antibiotics","volume":"14","author":"Chen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108592_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108592_bib152","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/antibiotics8040182","article-title":"Phage-antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy?","volume":"8","author":"Abedon","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108592_bib153","article-title":"The Current landscape of phage-antibiotic synergistic (PAS) interactions","volume":"14","author":"Supina","year":"2025","journal-title":"Antibiotics (Basel)."},{"key":"10.1016\/j.micpath.2026.108592_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010746","article-title":"Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: killers and drivers of resistance evolution","volume":"18","author":"Leclerc","year":"2022","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.micpath.2026.108592_bib155","series-title":"Clinical Microbiology and Infection","article-title":"Pharmacokinetics\/pharmacodynamics of phage therapy: a major hurdle to clinical translation","author":"Nang","year":"2023"},{"key":"10.1016\/j.micpath.2026.108592_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.594868","article-title":"Bacteriophage enumeration and detection methods","volume":"11","author":"\u00c1cs","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib157","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3389\/fmicb.2017.02170","article-title":"Real-Time qPCR as a method for detection of antibody-neutralized phage particles","volume":"8","author":"K\u0142opot","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313774","article-title":"Free DNA partially clarifies discrepancies between qPCR and the conventional phage quantification method","volume":"19","author":"Van Overfelt","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108592_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1659093","article-title":"Evaluating phage lytic activity: from plaque assays to single-cell technologies","volume":"16","author":"Panteleev","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics14060553","article-title":"Current clinical laboratory challenges to widespread adoption of phage therapy in the United States","volume":"14","author":"Kline","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108592_bib161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib162","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1038\/s41467-025-61268-1","article-title":"Macrophage-induced reduction of bacteriophage density limits the efficacy of in vivo pulmonary phage therapy","volume":"16","author":"Zborowsky","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108592_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78464-2","article-title":"Scavenger receptor MARCO contributes to cellular internalization of exosomes by dynamin-dependent endocytosis and macropinocytosis","volume":"10","author":"Kanno","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108592_bib164","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/nano15151189","article-title":"Surface charge affects the intracellular fate and clearance dynamics of CdSe\/ZnS quantum dots in macrophages","volume":"15","author":"Liu","year":"2025","journal-title":"Nanomaterials"},{"key":"10.1016\/j.micpath.2026.108592_bib165","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/cr.2010.94","article-title":"Enemy at the gates: dendritic cells and immunity to mucosal pathogens","volume":"20","author":"Soloff","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.micpath.2026.108592_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1681461","article-title":"Neutrophils, not macrophages, aid phage-mediated control of pulmonary Pseudomonas aeruginosa infection","volume":"16","author":"Weissfuss","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/v9060150","article-title":"Phage-Phagocyte interactions and their implications for phage application as therapeutics","volume":"9","author":"Jo\u0144czyk-Matysiak","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib168","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0854.2006.00528.x","article-title":"Macrophage activation downregulates the degradative capacity of the phagosome","volume":"8","author":"Yates","year":"2007","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/j.micpath.2026.108592_bib169","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coi.2013.11.003","article-title":"Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes","volume":"26","author":"Moretti","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib170","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9691","article-title":"Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection","volume":"363","author":"Sweere","year":"2019","journal-title":"Science."},{"key":"10.1016\/j.micpath.2026.108592_bib171","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/138920112804583087","article-title":"Pattern recognition receptors and control of innate immunity: role of nucleic acids","volume":"19","author":"Fischer","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108592_bib172","article-title":"Cell surface expression of endosomal toll-like Receptors-A necessity or a superfluous duplication?","volume":"11","author":"Mielcarska","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib173","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","article-title":"The innate immune response to bacterial flagellin is mediated by toll-like receptor 5","volume":"410","author":"Hayashi","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108592_bib174","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcimb.2013.00037","article-title":"Nucleic acids and endosomal pattern recognition: how to tell friend from foe?","volume":"3","author":"Brencicova","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.954581","article-title":"Regulation of cGAS\/STING signaling and corresponding immune escape strategies of viruses","volume":"12","author":"Ge","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib176","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.coviro.2011.04.004","article-title":"RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity","volume":"1","author":"Ramos","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.micpath.2026.108592_bib177","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.micpath.2026.108592_bib178","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.4161\/21645515.2014.979640","article-title":"Mechanisms and pathways of innate immune activation and regulation in health and cancer","volume":"10","author":"Cui","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.micpath.2026.108592_bib179","doi-asserted-by":"crossref","DOI":"10.1038\/srep14802","article-title":"Mammalian host-versus-phage immune response determines phage fate in vivo","volume":"5","author":"Hodyra-Stefaniak","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108592_bib180","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9691","article-title":"Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection","volume":"363","author":"Sweere","year":"2019","journal-title":"Science."},{"key":"10.1016\/j.micpath.2026.108592_bib181","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002341","article-title":"Mammalian cells internalize bacteriophages and use them as a resource to enhance cellular growth and survival","volume":"21","author":"Bichet","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.micpath.2026.108592_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108592_bib183","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108592_bib184","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib185","doi-asserted-by":"crossref","DOI":"10.1093\/femsml\/uqad044","article-title":"T5-like phage BF23 evades host-mediated DNA restriction and methylation","volume":"4","author":"Skutel","year":"2023","journal-title":"microLife"},{"key":"10.1016\/j.micpath.2026.108592_bib186","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1038\/s41467-022-35203-7","article-title":"The coordination of anti-phage immunity mechanisms in bacterial cells","volume":"13","author":"Arias","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108592_bib187","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451543","article-title":"Differences in phage recognition and immunogenicity contribute to divergent human immune responses to Escherichia coli and Klebsiella pneumoniae phages","volume":"55","author":"Le","year":"2025","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141600","article-title":"BSRF1 modulates IFN-\u03b2-mediated antiviral responses by inhibiting NF-\u03baB activity via an IKK-dependent mechanism in Epstein-Barr virus infection","volume":"306","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2026.108592_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012828","article-title":"White spot syndrome virus immediate-early protein (wsv100) antagonizes the NF-\u03baB pathway to inhibit innate immune response in shrimp","volume":"21","author":"Xiao","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108592_bib190","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2524540","article-title":"Gut bacteriophages induce specific-reprogramming of macrophages to generate a protective innate immunity response to lipopolysaccharide exposure","volume":"17","author":"Hou","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.micpath.2026.108592_bib191","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.micpath.2026.108592_bib192","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1006\/clin.1993.1081","article-title":"Regulation of antibody responses: the role of complement and adhesion molecules","volume":"67","author":"Ochs","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.micpath.2026.108592_bib193","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00281-017-0644-y","article-title":"Complement as a regulator of adaptive immunity","volume":"40","author":"Killick","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.micpath.2026.108592_bib194","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.20042239","article-title":"Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1","volume":"201","author":"Gatto","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2026.108592_bib195","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/1535370221995154","article-title":"Bacteriophages immunomodulate the response of monocytes","volume":"246","author":"Perea","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.micpath.2026.108592_bib196","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1038\/s41467-024-46555-7","article-title":"Bacteriophage DNA induces an interrupted immune response during phage therapy in a chicken model","volume":"15","author":"Podlacha","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108592_bib197","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1038\/s41598-017-08336-9","article-title":"Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages","volume":"7","author":"Van Belleghem","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108592_bib198","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1751-7915.2008.00028.x","article-title":"PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response","volume":"1","author":"Kim","year":"2008","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108592_bib199","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/tra.12026","article-title":"Presentation of phagocytosed antigens by MHC class I and II","volume":"14","author":"Mantegazza","year":"2013","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/j.micpath.2026.108592_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101729","article-title":"Pathways of MHC I cross-presentation of exogenous antigens","volume":"66","author":"Cruz","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib201","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fimmu.2012.00389","article-title":"Dendritic cells enhance the antigen sensitivity of T cells","volume":"3","author":"Garbi","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2007.00552.x","article-title":"Phagocytosis and antigen presentation in dendritic cells","volume":"219","author":"Savina","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micpath.2026.108592_bib203","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20161533","article-title":"Differentiation of germinal center B cells into plasma cells is initiated by high-affinity antigen and completed by Tfh cells","volume":"214","author":"Kr\u00e4utler","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2026.108592_bib204","first-page":"91","article-title":"Natural and induced antibodies against phages in humans: induction kinetics and immunogenicity for structural proteins of PB1-Related phages","volume":"1","author":"Hodyra-Stefaniak","year":"2020","journal-title":"Phage"},{"key":"10.1016\/j.micpath.2026.108592_bib205","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3389\/fimmu.2019.02607","article-title":"Induction of phage-specific antibodies by two therapeutic staphylococcal bacteriophages administered per os","volume":"10","author":"Majewska","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib206","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.3390\/v7082845","article-title":"Oral application of T4 phage induces weak antibody production in the gut and in the blood","volume":"7","author":"Majewska","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239254","article-title":"Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells","volume":"21","author":"Pietrzak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108592_bib208","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/mi.2012.51","article-title":"IgA is important for clearance and critical for protection from rotavirus infection","volume":"5","author":"Blutt","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib209","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41577-019-0261-1","article-title":"Rethinking mucosal antibody responses: igm, IgG and IgD join IgA","volume":"20","author":"Chen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib210","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/JB.187.13.4531-4541.2005","article-title":"Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection","volume":"187","author":"De Haard","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108592_bib211","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1128\/JVI.02043-14","article-title":"Immunogenicity studies of proteins forming the T4 phage head surface","volume":"88","author":"D\u0105browska","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2026.108592_bib212","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01418-25","article-title":"mGem: immune recognition and clearance of bacteriophages-implications for phage therapy","volume":"16","author":"Le","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108592_bib213","article-title":"Evaluation of the impact of repeated intravenous phage doses on mammalian host\u2013phage interactions","volume":"98","author":"Tan","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2026.108592_bib214","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12985-024-02552-2","article-title":"Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of delivery","volume":"22","author":"Smytheman","year":"2025","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2026.108592_bib215","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47192-w","article-title":"Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model","volume":"15","author":"Berkson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108592_bib216","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nature medicine"},{"key":"10.1016\/j.micpath.2026.108592_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.04.024","article-title":"Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection","volume":"185","author":"Nick","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108592_bib218","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11101358","article-title":"Do anti-phage antibodies persist after phage therapy? A preliminary report","volume":"11","author":"\u0141usiak-Szelachowska","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108592_bib219","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/S0264-410X(00)00561-2","article-title":"Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine","volume":"19","author":"Wan","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108592_bib220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/v15020387","article-title":"Repetitive exposure to bacteriophage cocktails against Pseudomonas aeruginosa or Escherichia coli provokes marginal humoral immunity in Na\u00efve mice","volume":"15","author":"Weissfuss","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108592_bib221","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/acschembio.8b00313","article-title":"Antitumor humoral and T cell responses by Mucin-1 conjugates of bacteriophage Q\u03b2 in wild-type mice","volume":"13","author":"Yin","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.micpath.2026.108592_bib222","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12026-017-8969-0","article-title":"Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8(+) T response","volume":"66","author":"Arab","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.micpath.2026.108592_bib223","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.491001","article-title":"Engineered bacteriophage T7 as a potent anticancer agent in vivo","volume":"11","author":"Hwang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib224","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108592_bib225","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5114\/ceji.2018.77390","article-title":"Immunological memory cells","volume":"43","author":"Ratajczak","year":"2018","journal-title":"Central-European journal of immunology"},{"key":"10.1016\/j.micpath.2026.108592_bib226","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.4049\/jimmunol.1601852","article-title":"Characterization of T-Dependent and T-Independent B cell responses to a virus-like particle","volume":"198","author":"Liao","year":"2017","journal-title":"Journal of immunology"},{"key":"10.1016\/j.micpath.2026.108592_bib227","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk0858","article-title":"Antiviral memory B cells exhibit enhanced innate immune response facilitated by epigenetic memory","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.micpath.2026.108592_bib228","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/894971","article-title":"Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses","volume":"2010","author":"Del Pozzo","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108592_bib229","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/EBC20240024","article-title":"Phage-specific antibodies: are they a hurdle for the success of phage therapy?","volume":"68","author":"Washizaki","year":"2024","journal-title":"Essays Biochem."},{"key":"10.1016\/j.micpath.2026.108592_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107660","article-title":"Nanomedicine for phage therapy: encapsulation strategies for enhanced antimicrobial efficacy","volume":"67","author":"Dorta-Gorr\u00edn","year":"2026","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108592_bib231","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.699054","article-title":"Nanotechnology based approaches in phage therapy: overcoming the pharmacological barriers","volume":"12","author":"Kaur","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108592_bib232","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.copbio.2020.11.011","article-title":"Phage-specific antibodies","volume":"68","author":"Gembara","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108592_bib233","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2249.1998.00713.x","article-title":"IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules","volume":"114","author":"Knolle","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.micpath.2026.108592_bib234","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/S0007114512005223","article-title":"Gut immune system and oral tolerance","volume":"109","author":"Castro-S\u00e1nchez","year":"2013","journal-title":"The British journal of nutrition"},{"key":"10.1016\/j.micpath.2026.108592_bib235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2022.03.007","article-title":"Oral tolerance: an updated review","volume":"245","author":"Rezende","year":"2022","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2026.108592_bib236","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-409X(98)00042-8","article-title":"Mucosal immunity of the gastrointestinal tract and oral tolerance","volume":"34","author":"Simecka","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2026.108592_bib237","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012435","article-title":"Biological foundations of successful bacteriophage therapy","volume":"14","author":"Venturini","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.micpath.2026.108592_bib238","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2524540","article-title":"Gut bacteriophages induce specific-reprogramming of macrophages to generate a protective innate immunity response to lipopolysaccharide exposure","volume":"17","author":"Hou","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.micpath.2026.108592_bib239","article-title":"Mechanistic insights and clinical implications of cross-reactive anti-prophage antibodies and bacterial heteroresistance on phage therapeutic failure","author":"Altamirano","year":"2025","journal-title":"bioRxiv : the preprint server for biology"},{"key":"10.1016\/j.micpath.2026.108592_bib240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.12793\/tcp.2023.31.e17","article-title":"Phage-host-immune system dynamics in bacteriophage therapy: basic principles and mathematical models","volume":"31","author":"Chae","year":"2023","journal-title":"Translational and Clinical Pharmacology"},{"key":"10.1016\/j.micpath.2026.108592_bib241","article-title":"Pharmacokinetics and biodistribution of phages and their Current applications in antimicrobial therapy","volume":"7","author":"Kang","year":"2023","journal-title":"Adv. Therapeut."},{"issue":"Supplement_5","key":"10.1016\/j.micpath.2026.108592_bib242","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad516","article-title":"Pharmacokinetic and pharmacodynamic obstacles for phage therapy from the perspective of clinical practice","volume":"77","author":"Mi\u0119dzybrodzki","year":"2023","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.micpath.2026.108592_bib243","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy","volume":"249","author":"Malik","year":"2017","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.micpath.2026.108592_bib244","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad555","article-title":"Advanced manufacturing, formulation and microencapsulation of therapeutic phages","volume":"77","author":"Malik","year":"2023","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.micpath.2026.108592_bib245","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.copbio.2021.02.009","article-title":"Approaches for manufacture, formulation, targeted delivery and controlled release of phage-based therapeutics","volume":"68","author":"Malik","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108592_bib246","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40560-024-00759-7","article-title":"Current status of bacteriophage therapy for severe bacterial infections","volume":"12","author":"Sawa","year":"2024","journal-title":"J. Intensiv. Care"},{"key":"10.1016\/j.micpath.2026.108592_bib247","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.1701745","article-title":"Contribution of the immune response to phage therapy","volume":"200","author":"Krut","year":"2018","journal-title":"Journal of immunology"},{"key":"10.1016\/j.micpath.2026.108592_bib248","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","article-title":"Immunogenicity of bacteriophages","volume":"31","author":"Champagne-Jorgensen","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2026.108592_bib249","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02071-21","article-title":"Considerations for the use of phage therapy in clinical practice","volume":"66","author":"Suh","year":"2022","journal-title":"Antimicrobial agents and chemotherapy"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026003189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026003189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:38:06Z","timestamp":1783751886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":249,"alternative-id":["S0882401026003189"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108592","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Connecting the dots between phage pharmacokinetics, pharmacodynamics and immune interactions","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108592"}}